Get the Most out of your Algal Strain with Algenuity
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Did you visit us at this year’s Algae Biomass Organization (ABO) Summit in Texas? Attendees were able to see our Algem® photobioreactor in action, and speak to us about our multiparametric optimization.
At Algenuity, we take a radically different statistical modeling approach to help you get the most from your algal strains. We can improve your process and outcome by discovering which parameters are most important and co-optimizing them, while also uncovering hidden parameter interactions. We statistically model your process to accurately predict better conditions, which rapidly increases your yields, defines tolerances, improves your process economics and decreases your time to market.
We have demonstrated successful application of this advanced scientific approach to increase the biomass yield of Arthrospira platensis (spirulina) by 235 %, and astaxanthin production in Haematococcus pluvialis to 6.9 % dry weight. “We are excited by the results we have achieved for these commercially important microalgae,” commented Andrew Spicer, Algenuity CEO. “We are confident in applying our expertize and technology to improve microalgal industry outputs, driving the industry to success, renewed investment and growth”.
At Algenuity, we take a radically different statistical modeling approach to help you get the most from your algal strains. We can improve your process and outcome by discovering which parameters are most important and co-optimizing them, while also uncovering hidden parameter interactions. We statistically model your process to accurately predict better conditions, which rapidly increases your yields, defines tolerances, improves your process economics and decreases your time to market.
We have demonstrated successful application of this advanced scientific approach to increase the biomass yield of Arthrospira platensis (spirulina) by 235 %, and astaxanthin production in Haematococcus pluvialis to 6.9 % dry weight. “We are excited by the results we have achieved for these commercially important microalgae,” commented Andrew Spicer, Algenuity CEO. “We are confident in applying our expertize and technology to improve microalgal industry outputs, driving the industry to success, renewed investment and growth”.
